Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Li-Fraumeni Syndrome and BRCA1[original query] |
|---|
| Mutation analysis of the CHK2 gene in families with hereditary breast cancer. British journal of cancer 2001 Jul 85 (2): 209-12. Allinen M, Huusko P, Mäntyniemi S, Launonen V, Winqvist R |
| CHEK2 1100delC is not a risk factor for male breast cancer population. International journal of cancer. Journal international du cancer 2004 Jan 108 (3): 475-6. Syrjäkoski Kirsi, Kuukasjärvi Tuula, Auvinen Anssi, Kallioniemi Olli |
| Is p53 intronic variant G13964C associated with predisposition to cancer? Journal of applied genetics 2003 44 (4): 547-52. Fiszer-Maliszewska ?ucja, Kazanowska Bernarda, Ku?nierczyk Piotr, Ma?czak Maria, Niepiek?o Wanda, Pochro?-Zeman Bogus?awa, Nowakowska Bea |
| Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families. Breast cancer research and treatment 2008 Apr 108 (3): 399-408. Arcand Suzanna L, Maugard Christine M, Ghadirian Parviz, Robidoux André, Perret Chantal, Zhang Phil, Fafard Eve, Mes-Masson Anne-Marie, Foulkes William D, Provencher Diane, Narod Steven A, Tonin Patricia |
| No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways. Familial cancer 2012 Aug . Penkert J, Schlegelberger B, Steinemann D, Gadzicki D |
| Routine TP53 testing for breast cancer under age 30: ready for prime time? Familial cancer 2012 Aug . McCuaig JM, Armel SR, Novokmet A, Ginsburg OM, Demsky R, Narod SA, Malkin D |
| Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast cancer research : BCR 2012 14 (2): R66. Lee Daphne S C, Yoon Sook-Yee, Looi Lai Meng, Kang Peter, Kang In Nee, Sivanandan Kavitta, Ariffin Hany, Thong Meow Keong, Chin Kin Fah, Mohd Taib Nur Aishah, Yip Cheng-Har, Teo Soo-Hwa |
| TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Hereditary cancer in clinical practice 2014 12 (1): 8. Cury Nathalia M, Ferraz Victor Ef, Silva Wilson |
| Germline TP53 mutational spectrum in French Canadians with breast cancer. BMC medical genetics 2015 16 24. Arcand Suzanna L, Akbari Mohammed R, Mes-Masson Anne-Marie, Provencher Diane, Foulkes William D, Narod Steven A, Tonin Patricia |
| Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome. Human mutation 2018 9 39 (12): 1764-1773. Fortuno Cristina, James Paul A, Spurdle Amanda |
| Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity. Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor |
| Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil. Breast cancer (Tokyo, Japan) 2018 12 26 (3): 397-405. Cipriano Nilson Moreira, de Brito Amanda Marques, de Oliveira Eneida Santos, de Faria Fabiana Castro, Lemos Sara, Rodrigues Angélica Nogueira, de Oliveira Lopes Débora, Dos Santos Luciana La |
| Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations. The breast journal 2018 11 25 (1): 16-19. Ditchi Yoan, Broudin Chloé, El Dakdouki Yolla, Muller Marie, Lavaud Pernelle, Caron Olivier, Lejri Donia, Baynes Caroline, Mathieu Marie-Christine, Salleron Julia, Benusiglio Patrick |
| Reproductive factors associated with breast cancer risk in Li-Fraumeni syndrome. European journal of cancer (Oxford, England : 1990) 2019 6 116 199-206. Khincha Payal P, Best Ana F, Fraumeni Joseph F, Loud Jennifer T, Savage Sharon A, Achatz Maria Isab |
| Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population. BMC cancer 2019 Feb 19 (1): 118. Gallardo-Alvarado Lenny N, Tusié-Luna María Teresa, Tussié-Luna María Isabel, Díaz-Chávez José, Segura Yayoi X, Bargallo-Rocha Enrique, Villarreal Cynthia, Herrera-Montalvo Luis A, Herrera-Medina Enrique M, Cantu-de Leon David |
| TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort. Familial cancer 2019 1 18 (2): 273-280. Bakhuizen J J, Hogervorst F B, Velthuizen M E, Ruijs M W, van Engelen K, van Os T A, Gille J J, Collée M, van den Ouweland A M, van Asperen C J, Kets C M, Mensenkamp A R, Leter E M, Blok M J, de Jong M M, Ausems M |
| Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients. Hereditary cancer in clinical practice 2021 12 19 (1): 49. Siraj Abdul Khalid, Masoodi Tariq, Bu Rong, Parvathareddy Sandeep Kumar, Iqbal Kaleem, Azam Saud, Al-Rasheed Maha, Ajarim Dahish, Tulbah Asma, Al-Dayel Fouad, Al-Kuraya Khawla Sa |
| TP53 Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes. Biomolecules 2022 5 12 (5): . da Silva Paula Francinete Faustino, Goveia Rebeca Mota, Teixeira Thaís Bomfim, Gamba Bruno Faulin, de Lima Aliny Pereira, Rogatto Sílvia Regina, Silveira-Lacerda Elisângela de Pau |
| Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022 2 13 (2): . Vietri Maria Teresa, D'Elia Giovanna, Caliendo Gemma, Albanese Luisa, Signoriello Giuseppe, Napoli Claudio, Molinari Anna Mar |
- Page last reviewed:Feb 1, 2024
- Content source: